New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: Outside-in signaling and relationship to tumor progression

被引:493
作者
Bauvois, Brigitte [1 ]
机构
[1] Univ Paris 05, Univ Paris 06, INSERM, U872,Ctr Rech Cordeliers, F-75270 Paris 06, France
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2012年 / 1825卷 / 01期
关键词
Gelatinase; Cell surface binding; Cancer; Inhibitor; Function; Outside-in signaling; CHRONIC LYMPHOCYTIC-LEUKEMIA; INTEGRIN ALPHA(V)BETA(3); HEMOPEXIN DOMAIN; BREAST-CANCER; BONE-MARROW; TISSUE INHIBITORS; KAPOSIS-SARCOMA; MATRIX-METALLOPROTEINASE-9; MIGRATION; ASSOCIATION;
D O I
10.1016/j.bbcan.2011.10.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
This review focuses on matrix metalloproteinases (MMPs)-2 (gelatinase A) and -9 (gelatinase B), both of which are cancer-associated, secreted, zinc-dependent endopeptidases. Gelatinases cleave many different targets (extracellular matrix, cytokines, growth factors, chemokines and cytokine/growth factor receptors) that in turn regulate key signaling pathways in cell growth, migration, invasion, inflammation and angiogenesis. Interactions with cell surface integral membrane proteins (CD44, aV beta/a beta 1/a beta 2 integrins and Ku protein) can occur through the gelatinases' active site or hemopexin-like C-terminal domain. This review evaluates the recent literature on the non-enzymatic, signal transduction roles of surface-bound gelatinases and their subsequent effects on cell survival, migration and angiogenesis. Gelatinases have long been drug targets. The current status of gelatinase inhibitors as anticancer agents and their failure in the clinic is discussed in light of these new data on the gelatinases' roles as cell surface transducers data that may lead to the design and development of novel, gelatinase-targeting inhibitors. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 112 条
[1]
Neutrophil MMP-9 Proenzyme, Unencumbered by TIMP-1, Undergoes Efficient Activation in Vivo and Catalytically Induces Angiogenesis via a Basic Fibroblast Growth Factor (FGF-2)/FGFR-2 Pathway [J].
Ardi, Veronica C. ;
Van den Steen, Philippe E. ;
Opdenakker, Ghislain ;
Schweighofer, Bernhard ;
Deryugina, Elena I. ;
Quigley, James P. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (38) :25854-25866
[2]
Matrix metalloproteinase-2 and-9 expression increases in Mycoplasma-infected airways but is not required for microvascular remodeling [J].
Baluk, P ;
Raymond, WW ;
Ator, E ;
Coussens, LM ;
McDonald, DM ;
Caughey, GH .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2004, 287 (02) :L307-L317
[3]
Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide [J].
Bannikov, GA ;
Karelina, TV ;
Collier, IE ;
Marmer, BL ;
Goldberg, GI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (18) :16022-16027
[4]
Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons [J].
Bauvois, B ;
Dumont, J ;
Mathiot, C ;
Kolb, JP .
LEUKEMIA, 2002, 16 (05) :791-798
[5]
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J].
Bergers, G ;
Brekken, R ;
McMahon, G ;
Vu, TH ;
Itoh, T ;
Tamaki, K ;
Tanzawa, K ;
Thorpe, P ;
Itohara, S ;
Werb, Z ;
Hanahan, D .
NATURE CELL BIOLOGY, 2000, 2 (10) :737-744
[6]
RETRACTED: Blockade of tumor growth due to matrix metalloproteinase-9 inhibition is mediated by sequential activation of β1-integrin, ERK, and NF-κB (Retracted article. See vol. 295, pg. 15426, 2020) [J].
Bhoopathi, Praveen ;
Chetty, Chandramu ;
Kunigal, Sateesh ;
Vanamala, Sravan K. ;
Rao, Jasti S. ;
Lakka, Sajani S. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (03) :1545-1552
[7]
Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion [J].
Björklund, M ;
Heikkilä, P ;
Koivunen, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (28) :29589-29597
[8]
Gelatinase-mediated migration and invasion of cancer cells [J].
Björklund, M ;
Koivunen, E .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2005, 1755 (01) :37-69
[9]
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion [J].
Bourboulia, Dimitra ;
Stetler-Stevenson, William G. .
SEMINARS IN CANCER BIOLOGY, 2010, 20 (03) :161-168
[10]
Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO